\-\ Texto\\:\\ \ \(0\)\
\-\ increase\\ from\\ last\\ documented\\ creat\\ of\\ 1\\.5\\ to\\ ed\\ value\\ of\\ 6\\.5\ \(0\)\
\-\ bilateral\\ percutaneous\\ nephrostomy\\ tubes\ \(0\)\
\-\ urology\\ consultation\\ with\\ treatment\\ per\\ their\\ recommendations\\ with\\ plan\\ for\\ resection\\ of\\ bladder\\ tumor\\ and\\ placement\\ of\\ double\\ j\\ stents\\.\ \(0\)\
\-\ old\\ ct\\ for\\ comparison\\:\\ mild\\ hydrouretonephrosis\ \(0\)\
\-\ new\\ ct\\ with\\ marked\\ increase\\ in\\ hydrouretonephrosis\\ with\\ distal\\ obstruction\\,\\ no\\ renal\\ or\\ ureter\\ calculi\\ identified\\,\\ foley\\ in\\ decompressed\\ bladder\\.\ \(0\)\
\-\ spot\\ ap\\ flouro\\ images\\ demonstrate\\ percutaneous\\ nephrosomy\\ placement\\ with\\ tubes\\ in\\ renal\\ pelvis\\.\\ dilated\\ ureters\\ without\\ proximal\\ obstuction\\.\ \(0\)\
\-\ percutaneous\\ nephrostomy\\ for\\ hydrouretonephrosis\\ secondary\\ to\\ malignant\\ distal\\ obstruction\ \(0\)\
\-\ distal\\ obstruction\\ due\\ to\\ prostate\\ cancer\ \(0\)\
\-\ distal\\ obstruction\\ due\\ to\\ bladder\\ cancer\ \(0\)\
\-\ male\\ with\\ prostate\\ \\&\\ bladder\\ cancer\ \(0\)\
\-\ prior\\ ct\\ with\\ mild\\ hydrouretonephrosis\ \(0\)\
\-\ presents\\ with\\ fall\\,\\ general\\ weakness\\,\\ tremor\\,\\ and\\ \\‚\\Ä\\úfeeling\\ poorly\\‚\\Ä\\ù\ \(0\)\
\-\ percutaneous\\ nephrostomy\\ is\\ commonly\\ indicated\\ for\\ one\\ of\\ four\\ reasons\\:\\ \ \(0\)\
\-\ 1\\.\\ relief\\ of\\ urinary\\ obstruction\ \(0\)\
\-\ \\	preservation\\ of\\ renal\\ function\\,\\ treatment\\ of\\ \\	infection\ \(0\)\
\-\ 2\\.\\ urinary\\ diversion\\ \ \(0\)\
\-\ \\	usually\\ for\\ urinary\\ tract\\ injury\\ but\\ may\\ also\\ \\	be\\ done\\ for\\ fistula\\ or\\ hemorrhagic\\ cystitis\ \(1\)\
\-\ 3\\.\\ access\\ for\\ therapeutic\\ interventions\\ \ \(0\)\
\-\ \\	antegrade\\ pyelogram\\ or\\ whitaker\\ test\ \(0\)\
\-\ 4\\.\\ access\\ for\\ diagnostic\\ interventions\ \(0\)\
\-\ \\	stone\\ therapy\\,\\ benign\\ strictures\\,\\ ureteral\\ \\	stent\\ placement\\ or\\ removal\\ of\\ foreign\\ bodies\ \(0\)\
\-\ percutaneous\\ nephrostomy\ \(7\)\
\-\ preprocedure\\:\\ screening\\ coags\\,\\ antibiotics\\ if\\ not\\ already\\ on\\ board\\ include\\ coverage\\ for\\ common\\ urinary\\ pathogens\\ with\\ infection\\;\\ however\\,\\ in\\ this\\ case\\ ancef\\ 1gram\\ would\\ be\\ adequate\\.\ \(0\)\
\-\ procedure\\:\\ using\\ ultrasound\\ guidance\\ in\\ a\\ posterior\\ lateral\\ approach\\ a\\ posterior\\ calyx\\ was\\ selected\\.\\ \\ urine\\ noted\\ to\\ flow\\ freely\\ from\\ the\\ needle\\ and\\ a\\ 0\\.018\\ guide\\ wire\\ was\\ placed\\ into\\ the\\ renal\\ pelvis\\.\\ using\\ a\\ 8\\ french\\ access\\ set\\ under\\ floroscopic\\ guidance\\ a\\ short\\ stiff\\ 0\\.038\\ wire\\ was\\ placed\\.\\ the\\ tract\\ was\\ subsequently\\ dilated\\ to\\ 8\\ french\\ and\\ 8\\ french\\ locking\\ pigtail\\ catheter\\ was\\ placed\\.\\ \ \(0\)\
\-\ complications\\:\\ possible\\ complications\\ include\\:\\ bleeding\\,\\ infection\\ if\\ not\\ already\\ present\\,\\ damage\\ to\\ kidney\\,\\ liver\\,\\ spleen\\,\\ bowel\\,\\ pneumothorax\\,\\ empyema\\,\\ and\\ urinomas\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hydrouretonephrosis\\:\\ 0\\.32644291061600994\ \(0\)\
\-\ nephrostomy\\:\\ 0\\.25680989280762945\ \(0\)\
\-\ percutaneous\\:\\ 0\\.24593554352389432\ \(0\)\
\-\ french\\:\\ 0\\.2076265108569584\ \(0\)\
\-\ obstruction\\:\\ 0\\.17872392812060384\ \(0\)\
\-\ urinary\\:\\ 0\\.1765190801636517\ \(0\)\
\-\ access\\:\\ 0\\.17127291728038305\ \(0\)\
\-\ bladder\\:\\ 0\\.15840257333530952\ \(0\)\
\-\ for\\:\\ 0\\.13920572968472691\ \(0\)\
\-\ renal\\:\\ 0\\.12711541701073498\ \(0\)\
\-\ wire\\:\\ 0\\.12115030540528776\ \(0\)\
\-\ placement\\:\\ 0\\.11954748403558649\ \(0\)\
\-\ placed\\:\\ 0\\.11929665773027642\ \(0\)\
\-\ interventions\\:\\ 0\\.11876114220442896\ \(0\)\
\-\ distal\\:\\ 0\\.11860264130308013\ \(0\)\
\-\ guidance\\:\\ 0\\.11476862515783486\ \(0\)\
\-\ tubes\\:\\ 0\\.1105391225776055\ \(0\)\
\-\ already\\:\\ 0\\.10832740360347776\ \(0\)\
\-\ cancer\\:\\ 0\\.10197207370228291\ \(0\)\
\-\ prostate\\:\\ 0\\.09885781836786471\ \(0\)\
\-\ infection\\:\\ 0\\.09247821939422352\ \(0\)\
\-\ with\\:\\ 0\\.08993372620821305\ \(0\)\
\-\ of\\:\\ 0\\.08988002291593801\ \(0\)\
\-\ to\\:\\ 0\\.08930469640366219\ \(0\)\
\-\ was\\:\\ 0\\.08892518685928164\ \(0\)\
\-\ tract\\:\\ 0\\.0855014535795286\ \(0\)\
\-\ using\\:\\ 0\\.08394463330023871\ \(0\)\
\-\ increase\\:\\ 0\\.08193216077502892\ \(0\)\
\-\ nephrosomy\\:\\ 0\\.08161072765400249\ \(0\)\
\-\ ancef\\:\\ 0\\.08161072765400249\ \(0\)\
\-\ 1gram\\:\\ 0\\.08161072765400249\ \(0\)\
\-\ floroscopic\\:\\ 0\\.08161072765400249\ \(0\)\
\-\ urinomas\\:\\ 0\\.08161072765400249\ \(0\)\
\-\ complications\\:\\ 0\\.0781695245722135\ \(0\)\
\-\ flouro\\:\\ 0\\.077983407154739\ \(0\)\
\-\ whitaker\\:\\ 0\\.077983407154739\ \(0\)\
\-\ preprocedure\\:\\ 0\\.077983407154739\ \(0\)\
\-\ obstuction\\:\\ 0\\.07540978230316096\ \(0\)\
\-\ pyelogram\\:\\ 0\\.07341352377986393\ \(0\)\
\-\ dilated\\:\\ 0\\.07309956287784558\ \(0\)\
\-\ coags\\:\\ 0\\.0717824618038975\ \(0\)\
\-\ calyx\\:\\ 0\\.0717824618038975\ \(0\)\
\-\ pigtail\\:\\ 0\\.0717824618038975\ \(0\)\
\-\ pelvis\\:\\ 0\\.07138370025168697\ \(0\)\
\-\ or\\:\\ 0\\.07101201780812114\ \(0\)\
\-\ diversion\\:\\ 0\\.07040341855274887\ \(0\)\
\-\ pathogens\\:\\ 0\\.07040341855274887\ \(0\)\
\-\ foley\\:\\ 0\\.06558151645305599\ \(0\)\
\-\ stiff\\:\\ 0\\.06558151645305599\ \(0\)\
\-\ creat\\:\\ 0\\.06486544853856772\ \(0\)\
\-\ board\\:\\ 0\\.06486544853856772\ \(0\)\
\-\ coverage\\:\\ 0\\.06486544853856772\ \(0\)\
\-\ antegrade\\:\\ 0\\.06420247320190736\ \(0\)\
\-\ freely\\:\\ 0\\.06420247320190736\ \(0\)\
\-\ guide\\:\\ 0\\.06358525792975894\ \(0\)\
\-\ in\\:\\ 0\\.06347509919494267\ \(0\)\
\-\ stents\\:\\ 0\\.06300789160147796\ \(0\)\
\-\ decompressed\\:\\ 0\\.06300789160147796\ \(0\)\
\-\ tremor\\:\\ 0\\.061954195953792514\ \(0\)\
\-\ locking\\:\\ 0\\.06101163307818091\ \(0\)\
\-\ include\\:\\ 0\\.06072674146966165\ \(0\)\
\-\ cystitis\\:\\ 0\\.06015898124185942\ \(0\)\
\-\ calculi\\:\\ 0\\.059761312524188745\ \(0\)\
\-\ recommendations\\:\\ 0\\.05938057110221448\ \(0\)\
\-\ if\\:\\ 0\\.05930132065154006\ \(0\)\
\-\ due\\:\\ 0\\.05866790419652436\ \(0\)\
\-\ strictures\\:\\ 0\\.058664503187726216\ \(0\)\
\-\ set\\:\\ 0\\.058664503187726216\ \(0\)\
\-\ ct\\:\\ 0\\.05828469175769032\ \(0\)\
\-\ mild\\:\\ 0\\.05785678984720605\ \(0\)\
\-\ urology\\:\\ 0\\.0560052693277688\ \(0\)\
\-\ preservation\\:\\ 0\\.05575325060295101\ \(0\)\
\-\ plan\\:\\ 0\\.05550813737682151\ \(0\)\
\-\ ureters\\:\\ 0\\.05550813737682151\ \(0\)\
\-\ empyema\\:\\ 0\\.055037182688462735\ \(0\)\
\-\ selected\\:\\ 0\\.054810687727339394\ \(0\)\
\-\ documented\\:\\ 0\\.054589785809915886\ \(0\)\
\-\ feeling\\:\\ 0\\.05416370180173888\ \(0\)\
\-\ reasons\\:\\ 0\\.05416370180173888\ \(0\)\
\-\ ureteral\\:\\ 0\\.05317962575137297\ \(0\)\
\-\ posterior\\:\\ 0\\.052777819015581845\ \(0\)\
\-\ and\\:\\ 0\\.05272533472628545\ \(0\)\
\-\ value\\:\\ 0\\.05196177736772086\ \(0\)\
\-\ therapeutic\\:\\ 0\\.05164224078953928\ \(0\)\
\-\ consultation\\:\\ 0\\.05148665298778976\ \(0\)\
\-\ stent\\:\\ 0\\.05148665298778976\ \(0\)\
\-\ ureter\\:\\ 0\\.05006364860097226\ \(0\)\
\-\ spot\\:\\ 0\\.04980432397692729\ \(0\)\
\-\ adequate\\:\\ 0\\.04967742719530048\ \(0\)\
\-\ damage\\:\\ 0\\.04967742719530048\ \(0\)\
\-\ spleen\\:\\ 0\\.04967742719530048\ \(0\)\
\-\ approach\\:\\ 0\\.048951672140605806\ \(0\)\
\-\ treatment\\:\\ 0\\.04861817120947257\ \(0\)\
\-\ comparison\\:\\ 0\\.048609742376497886\ \(0\)\
\-\ relief\\:\\ 0\\.047859332488526286\ \(0\)\
\-\ needle\\:\\ 0\\.04735942182250572\ \(0\)\
\-\ stone\\:\\ 0\\.046613483853200834\ \(0\)\
\-\ foreign\\:\\ 0\\.0462626124860432\ \(0\)\
\-\ poorly\\:\\ 0\\.046092205941288836\ \(0\)\
\-\ fistula\\:\\ 0\\.046092205941288836\ \(0\)\
\-\ urine\\:\\ 0\\.04567987152671652\ \(0\)\
\-\ catheter\\:\\ 0\\.04536316329920867\ \(0\)\
\-\ double\\:\\ 0\\.04498242187723441\ \(0\)\
\-\ bodies\\:\\ 0\\.04468908172511133\ \(0\)\
\-\ pneumothorax\\:\\ 0\\.04447522118790689\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.044266353962746155\ \(0\)\
\-\ short\\:\\ 0\\.04386270325013075\ \(0\)\
\-\ subsequently\\:\\ 0\\.043539705239092494\ \(0\)\
\-\ fall\\:\\ 0\\.042521327730869474\ \(0\)\
\-\ per\\:\\ 0\\.04235305807209361\ \(0\)\
\-\ their\\:\\ 0\\.04235305807209361\ \(0\)\
\-\ under\\:\\ 0\\.0422426113222667\ \(0\)\
\-\ indicated\\:\\ 0\\.04197231665011936\ \(0\)\
\-\ bleeding\\:\\ 0\\.041709949661445\ \(0\)\
\-\ last\\:\\ 0\\.04150545908713858\ \(0\)\
\-\ test\\:\\ 0\\.04150545908713858\ \(0\)\
\-\ screening\\:\\ 0\\.041455058541962464\ \(0\)\
\-\ be\\:\\ 0\\.04140300545302125\ \(0\)\
\-\ four\\:\\ 0\\.04135510137797093\ \(0\)\
\-\ function\\:\\ 0\\.041305538519307586\ \(0\)\
\-\ general\\:\\ 0\\.04096608038751446\ \(0\)\
\-\ ed\\:\\ 0\\.04082445094230329\ \(0\)\
\-\ procedure\\:\\ 0\\.040685028799283054\ \(0\)\
\-\ done\\:\\ 0\\.040593273398970724\ \(0\)\
\-\ from\\:\\ 0\\.040535220534210166\ \(0\)\
\-\ not\\:\\ 0\\.04029216778853874\ \(0\)\
\-\ removal\\:\\ 0\\.03900797148751625\ \(0\)\
\-\ diagnostic\\:\\ 0\\.038894007231606\ \(0\)\
\-\ marked\\:\\ 0\\.03859701487567367\ \(0\)\
\-\ commonly\\:\\ 0\\.03776097599325628\ \(0\)\
\-\ antibiotics\\:\\ 0\\.03759621860904454\ \(0\)\
\-\ weakness\\:\\ 0\\.03724409156455921\ \(0\)\
\-\ ap\\:\\ 0\\.0366373456594412\ \(0\)\
\-\ malignant\\:\\ 0\\.036377183035010946\ \(0\)\
\-\ identified\\:\\ 0\\.0361799387875633\ \(0\)\
\-\ would\\:\\ 0\\.03612437293745555\ \(0\)\
\-\ kidney\\:\\ 0\\.03585160567661154\ \(0\)\
\-\ new\\:\\ 0\\.035304513736297075\ \(0\)\
\-\ liver\\:\\ 0\\.03520399500342136\ \(0\)\
\-\ benign\\:\\ 0\\.035055303384789585\ \(0\)\
\-\ possible\\:\\ 0\\.03457678969884845\ \(0\)\
\-\ flow\\:\\ 0\\.0339906912340943\ \(0\)\
\-\ injury\\:\\ 0\\.033277980825033505\ \(0\)\
\-\ bowel\\:\\ 0\\.03274986253574747\ \(0\)\
\-\ resection\\:\\ 0\\.032711955389595815\ \(0\)\
\-\ usually\\:\\ 0\\.03212631824097464\ \(0\)\
\-\ proximal\\:\\ 0\\.03188168381134002\ \(0\)\
\-\ ultrasound\\:\\ 0\\.0314772726692026\ \(0\)\
\-\ the\\:\\ 0\\.030547993493781195\ \(0\)\
\-\ secondary\\:\\ 0\\.030247749440708852\ \(0\)\
\-\ however\\:\\ 0\\.030204773826727184\ \(0\)\
\-\ therapy\\:\\ 0\\.029320996161013694\ \(0\)\
\-\ one\\:\\ 0\\.029218018642892845\ \(0\)\
\-\ common\\:\\ 0\\.028940794195312796\ \(0\)\
\-\ prior\\:\\ 0\\.028552301214837376\ \(0\)\
\-\ bilateral\\:\\ 0\\.027426295081484635\ \(0\)\
\-\ into\\:\\ 0\\.02712754985519578\ \(0\)\
\-\ noted\\:\\ 0\\.0270569093169824\ \(0\)\
\-\ without\\:\\ 0\\.026917279923423944\ \(0\)\
\-\ tumor\\:\\ 0\\.02669251694719795\ \(0\)\
\-\ demonstrate\\:\\ 0\\.026529943533877533\ \(0\)\
\-\ present\\:\\ 0\\.02618600018227017\ \(0\)\
\-\ may\\:\\ 0\\.02568073846049851\ \(0\)\
\-\ case\\:\\ 0\\.02563774907884766\ \(0\)\
\-\ lateral\\:\\ 0\\.025325890177024444\ \(0\)\
\-\ but\\:\\ 0\\.02523523366270314\ \(0\)\
\-\ presents\\:\\ 0\\.024548860710753104\ \(0\)\
\-\ also\\:\\ 0\\.024003828475885676\ \(0\)\
\-\ images\\:\\ 0\\.02360553843841709\ \(0\)\
\-\ male\\:\\ 0\\.022721256375486495\ \(0\)\
\-\ this\\:\\ 0\\.01753539602497081\ \(0\)\
\-\ no\\:\\ 0\\.016594913873431025\ \(0\)\
\-\ on\\:\\ 0\\.015412436072613448\ \(0\)\
\-\ old\\:\\ 0\\.01510331762103212\ \(0\)\
\-\ is\\:\\ 0\\.013975365719783276\ \(0\)\
